Skip to content

Validation of a Modified Sphygmomanometer Test for the Assessment of Handgrip Strength in Patients with Stable Chronic Obstructive Pulmonary Disease

Validation of a Modified Sphygmomanometer Test for the Assessment of Handgrip Strength in Patients with Stable Chronic Obstructive Pulmonary Disease

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250118007
Enrollment
10
Registered
2025-01-18
Start date
2024-12-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

we would like to assess the validity of hand grip strength measured by Modified Sphygmomanometer test compared with standard handgrip dynamometer in stable chronic obstructive pulmonary disease patients COPD, handgrip strength, handgrip dynamometer, modified sphygmomanometer test

Interventions

for handgrip strength evaluation
modified sphygnomanometer

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Chronic Obstructive Pulmonary Disease (COPD) aged between 40 and 80 years 2. confirmed by a pulmonary function test (Spirometry) showing a Postbronchodilator Forced Expiratory Volume in 1 second (FEV1) / Forced Vital Capacity (FVC) ratio of less than 70%. 3. Volunteers must have stable vital signs on the day of testing, as follows: Systolic blood pressure should be between 90-160 mmHg. Heart rate should be between 50-140 beats per minute. The oxygen saturation (SpO2) at the fingertip should be more than 94% on room air, or if the volunteer is on long-term oxygen therapy, the oxygen saturation on the day of testing should not be less than 3% below the baseline level.

Exclusion criteria

Exclusion criteria: 1. Volunteers with a history of hospitalization or treatment for Chronic Obstructive Pulmonary Disease (COPD) symptoms within the past 3 months, or with a history of receiving steroids (both oral and intravenous) within the past 6 weeks. 2. Volunteers experiencing an exacerbation on the day of testing or having a respiratory rate greater than 24 breaths per minute. 3. Volunteers with a history of weakness in the face, arms, and muscles involved in respiration. 4. Volunteers who are unable to use the Peak Inspiratory Flow measuring device (In-Check DIAL). 5. Volunteers who are unable to use the Handgrip Strength measuring device. 6. Volunteers who breathe through a tracheostomy tube. 7. Volunteers who require invasive mechanical ventilation.

Design outcomes

Primary

MeasureTime frame
validation of handgrip strength at the moment validation of handgrip strength

Secondary

MeasureTime frame
- - -,N/A N/A N/A

Countries

Thailand

Contacts

Public ContactPhosathorn Buntangtaeng

Faculty of Medicine Vajira Hospital Navamindradhiraj University

phosathorn.bun@nmu.ac.th0613869922

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026